Clinical Trials Logo

Language Disorders clinical trials

View clinical trials related to Language Disorders.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06062147 Active, not recruiting - Clinical trials for Language Disorders in Children

Impact of Teacher Training and the Introduction of Early Adjustments on the Developmental Trajectory of Children at Risk of SLLD in Pre-school.

PRISME-TSLA
Start date: September 22, 2023
Phase: N/A
Study type: Interventional

The high incidence of neurodevelopmental disorders, including specific language and learning disorders, and their profund impact on the schooling of the children concerned remains a major public health concern. Early identification and intervention are a valuable tool for improving these problems. The developmental trajectory of children could be improved by knowledge enhancement, identification and strategies to support the teachers through the involvement of health professionals in the classroom

NCT ID: NCT05900180 Active, not recruiting - Pediatric Clinical Trials

Pediatric Speech Therapy Session Frequency and Speech Outcomes

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare speech therapy outcomes in children ages 18 months to 16 years who participate in weekly speech therapy with home programming versus every-other week speech therapy with home programming in outpatient speech therapy. The main question it aims to answer is: Does a change in how often speech therapy sessions are delivered show an increased benefit in language and articulation standardized test scores? Participants will be randomly assigned to either (1) weekly or (2) every-other-week speech therapy for a total of 8 sessions. Researchers will compare these two groups to see if there are differences in speech outcomes.

NCT ID: NCT05520528 Active, not recruiting - Stroke Clinical Trials

Impact of Group Participation on Adults With Aphasia

Start date: September 6, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the impact of group participation on adults with aphasia. Participants will complete a standard pre-and post-assessment of language abilities (speech, comprehension, reading, and/or writing). Then participants will attend 90-minute weekly reading group sessions during an academic semester.

NCT ID: NCT05325333 Active, not recruiting - Clinical trials for Language Development

Retrieval-Based Word Learning in Developmental Language Disorder

Start date: March 16, 2022
Phase: N/A
Study type: Interventional

Children with developmental language disorder (DLD; also referred to as specific language impairment) experience a significant deficit in language ability that is longstanding and harmful to the children's academic, social, and eventual economic wellbeing. Word learning is one of the principal weaknesses in these children. This project focuses on the word learning abilities of four- and five-year-old children with DLD. The goal of the project is to build on our previous work to determine whether, as we have found thus far, special benefits accrue when these children must frequently recall newly introduced words during the course of learning. In this first of a series of studies, we seek to increase the children's absolute levels of learning while maintaining the advantage that repeated retrieval holds over comparison methods of learning.

NCT ID: NCT04937452 Active, not recruiting - Dementia Clinical Trials

Dopaminergic Therapy for Frontotemporal Dementia Patients

Start date: June 3, 2021
Phase: Phase 2
Study type: Interventional

This is a phase IIa 24-week randomized, double-blind, placebo-controlled study. The study is designed to evaluate the efficacy and safety of Rotigotine (RTG) transdermal administration at the dosage of 4 mg or 6 mg per day versus Placebo (PLC) in newly diagnosed behavioural Frontotemporal Dementia (bvFTD) patients. 75 patients with a diagnosis of probable bvFTD will be randomly allocated to the 3 treatment arms (RTG 4mg/day, RTG 6mg/day or PLC), with 25 patients per group. Clinical and neurophysiological measurements and brain metabolism via FDG-PET will be collected before and after drug administration.

NCT ID: NCT03782493 Active, not recruiting - Clinical trials for Developmental Language Disorder

Maximizing Outcomes for Preschoolers With Developmental Language Disorders

Start date: April 4, 2019
Phase: Phase 2
Study type: Interventional

The objective of the proposed study is to evaluate the efficacy of the Enhanced Milieu Teaching-Sentence Focus (EMT-SF) intervention, implemented by caregivers and interventionists, relative to a control condition enrolling 108 30-month-old children and their caregivers. The central hypothesis is that intervention will result in better overall child language skills at 49 months of age.

NCT ID: NCT02839915 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

Start date: August 13, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effectiveness of folinic acid in the treatment of language problems in children with autism spectrum disorder. Folinic acid, also known as leucovorin, is approved by the U.S. Food and Drug Administration (FDA) to decrease side effects during cancer chemotherapy. Folinic acid may be helpful in treating language problems in children with autism spectrum disorder, but this is not known. Therefore, folinic acid is an investigational new drug for this study. Investigators will enroll a total of 134 participants across all three centers, over a 5 year period and participation will last between 12 and 24 weeks.

NCT ID: NCT00625261 Active, not recruiting - Language Delay Clinical Trials

Effectiveness of Early Parent-Based Language Intervention

Start date: October 2003
Phase: Phase 3
Study type: Interventional

The purpose of the study is to examine the effectiveness of a highly-structured parent-based language intervention group program for two-year-old children with language delay.